Frontlight ResearchEarly access
Pancreatic cancer trials in Denmark
5 of 33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Copenhagen
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleObservational Copenhagen Pancreatic Cancer Study
- Where
- Herlev
- People
- 8,000
- Run by
- Inna Chen, MD
See details and how to joinNCT06713525 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Odense
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleThe Role of Microbiota in Pancreatic Cancer and Precursor Lesions
- Where
- Herlev
- Age
- 18 years and over
- People
- 300
- Run by
- Herlev Hospital
See details and how to joinNCT07250100 - No phaseTaking peopleBIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
- Where
- Herlev
- Age
- 19 years and over
- People
- 5,000
- Run by
- Inna Chen, MD
See details and how to joinNCT03311776